Brief: Kane Biotech says entered into license and distribution agreement with Dechra Veterinary Products
06/03/2017 12:36
March 6 (Reuters) - Kane Biotech Inc KNE.V
* Kane biotech inc- terms of agreement are confidential
between parties and further financial details are not disclosed
* Kane biotech inc - has entered into exclusive license and
distribution agreement with dechra veterinary products llc, unit
of dechra pharmaceuticals
* Kane biotech- to receive upfront payment upon signing
along with series of potential payments to combined maximum of
usd $2.0 million
* Kane biotech inc - will receive an ongoing royalty on net
sales of its products by dechra in north america
Source text for Eikon: ID:nCCNrm7FM
Further company coverage: KNE.V
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Kane Biotech
See all newsBrief: Kane Biotech Announces FDA 510(K) Clearance For Revyve® Antimicrobial Skin And Wound Cleanser
Brief: Kane Biotech Restarts Commercial Activities And Strengthens North American Management
Brief: Kane Biotech Completes U.S. FDA 510(K) Submission For Revyve Antimicrobial Wound Cleanser
Brief: Kane Biotech Announces Second Quarter 2025 Financial Results
Brief: Kane Biotech provides further corporate update